3-179819883-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016559.3(PEX5L):āc.916G>Cā(p.Val306Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000867 in 1,614,094 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_016559.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PEX5L | NM_016559.3 | c.916G>C | p.Val306Leu | missense_variant | 9/15 | ENST00000467460.6 | NP_057643.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PEX5L | ENST00000467460.6 | c.916G>C | p.Val306Leu | missense_variant | 9/15 | 1 | NM_016559.3 | ENSP00000419975.1 |
Frequencies
GnomAD3 genomes AF: 0.000434 AC: 66AN: 152156Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000123 AC: 31AN: 251422Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135884
GnomAD4 exome AF: 0.0000506 AC: 74AN: 1461820Hom.: 0 Cov.: 30 AF XY: 0.0000330 AC XY: 24AN XY: 727210
GnomAD4 genome AF: 0.000433 AC: 66AN: 152274Hom.: 0 Cov.: 32 AF XY: 0.000483 AC XY: 36AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2021 | The c.916G>C (p.V306L) alteration is located in exon 9 (coding exon 9) of the PEX5L gene. This alteration results from a G to C substitution at nucleotide position 916, causing the valine (V) at amino acid position 306 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at